CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.270
-0.010 (-0.44%)
May 13, 2025, 4:00 PM - Market closed

CytoMed Therapeutics Income Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
0.07----
Upgrade
Other Revenue
0.430.510.360.110.06
Upgrade
Revenue
0.50.510.360.110.06
Upgrade
Revenue Growth (YoY)
-0.86%39.52%219.67%91.43%-
Upgrade
Cost of Revenue
0.0300.0100
Upgrade
Gross Profit
0.470.50.360.110.05
Upgrade
Selling, General & Admin
0.650.490.210.170.14
Upgrade
Research & Development
1.911.591.521.091.04
Upgrade
Other Operating Expenses
0.922.160.370.490.11
Upgrade
Operating Expenses
3.64.352.211.851.37
Upgrade
Operating Income
-3.13-3.84-1.86-1.74-1.32
Upgrade
Interest Expense
-0.02-0.05-0.13-0.12-0.11
Upgrade
Interest & Investment Income
0.320.2900-
Upgrade
Earnings From Equity Investments
0.01-0.03-0.03-0.21-
Upgrade
Currency Exchange Gain (Loss)
0.16-0.17-0.03-0.01-0
Upgrade
Other Non Operating Income (Expenses)
0.14-0.22---
Upgrade
EBT Excluding Unusual Items
-2.52-4.03-2.04-2.08-1.42
Upgrade
Gain (Loss) on Sale of Assets
--0--
Upgrade
Other Unusual Items
--0.1-1.090.02-0.51
Upgrade
Pretax Income
-2.52-4.13-3.13-2.05-1.94
Upgrade
Income Tax Expense
-00--
Upgrade
Earnings From Continuing Operations
-2.52-4.13-3.13-2.05-1.94
Upgrade
Minority Interest in Earnings
0.010000
Upgrade
Net Income
-2.52-4.13-3.13-2.05-1.94
Upgrade
Net Income to Common
-2.52-4.13-3.13-2.05-1.94
Upgrade
Shares Outstanding (Basic)
1211876
Upgrade
Shares Outstanding (Diluted)
1211876
Upgrade
Shares Change (YoY)
8.56%34.30%14.14%17.59%6.22%
Upgrade
EPS (Basic)
-0.22-0.39-0.40-0.30-0.33
Upgrade
EPS (Diluted)
-0.22-0.39-0.40-0.30-0.33
Upgrade
Free Cash Flow
-4.11-3.59-1.87-2.3-1.09
Upgrade
Free Cash Flow Per Share
-0.36-0.34-0.24-0.33-0.19
Upgrade
Gross Margin
93.83%99.27%97.60%96.92%92.22%
Upgrade
Operating Margin
-621.91%-756.86%-511.02%-1528.84%-2215.85%
Upgrade
Profit Margin
-499.97%-813.98%-860.43%-1802.21%-3254.59%
Upgrade
Free Cash Flow Margin
-816.52%-706.96%-514.47%-2016.27%-1839.93%
Upgrade
EBITDA
-2.8-3.46-1.47-1.41-1.03
Upgrade
D&A For EBITDA
0.330.380.390.330.29
Upgrade
EBIT
-3.13-3.84-1.86-1.74-1.32
Upgrade
Advertising Expenses
0.020.03-00.01
Upgrade
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q